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Abstract
Background: Cervical ripening resembles an inflammatory reaction. Estrogens induce leukocyte
migration into tissue and factors promoting cervical remodeling and labor, although the
mechanisms are only partially known. The aim of this study was to investigate whether plasma
membrane receptor mediated pathways, known to be activated by estrogens and proinflammatory
compounds, are involved in cervical ripening before labor.
Methods: The expression and distribution of mitogen activated protein kinases (MAPK), which
transduce extracellular signals into intracellular responses through phosphorylation, and their
intracellular targets transcription factors c-Jun and c-Fos proteins (AP-1) were analysed in cervical
biopsies from term pregnant women (TP), immediately after parturition (PP), and from non-
pregnant women (NP). Immunohistochemistry and RT-PCR techniques were used.
Results: Cell-specific alterations in the immunostaining pattern for MAPK were observed. The
expressions of activated, phosphorylated MAPK forms pERK1/2, pJNK and p38MAPK were
significantly increased in cervical stroma until TP and pERK1/2 expression was significantly
enhanced in PP group. c-Jun was significantly increased in cervical stroma and smooth muscle in TP
as compared to NP group. c-Fos was significantly increased in stroma, squamous epithelium and
glandular epithelium in PP as compared to TP group.
Conclusion: We report, for the first time, cell-specific activation of pMAPKs and their targets
transcription factors c-Fos and c-Jun (AP-1) proteins in human uterine cervix until term pregnancy,
and immediately after parturition. These results suggest a role for MAPK activation in cervical
ripening before labor.
Background
Cervical remodeling is a prerequisite for effacement and
dilatation prior to labor and is characterized by an
increase in vascular adhesion molecules, diapedesis and
activation of neutrophils, T-cells, monocytes/macro-
phages, mast cells, eosinophils, and increased concentra-
tions of metalloproteinases [1-5].
Metalloproteinase enzymes effectuate an altered prote-
oglycan composition and increased collagen solubility,
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which allows for extracellular matrix remodeling and an
increased cervical distensability [5-8]. Maternal plasma
levels of estrogens increase exponentially until term preg-
nancy and at labor concomitant with unchanged or
decreased progesterone levels [7,9,10]. The exact mecha-
nisms leading to parturition in humans remain unclear,
although previous studies have proposed that estrogens
may contribute to extracellular matrix remodeling and
inflammatory changes [1,10-12]. The suggested effects of
estrogens during cervical ripening appear to be highly cell-
type specific [11,12].
Mitogen activated protein kinases (MAPK) comprise pro-
line-directed second messenger systems, used by eukaryo-
tic cells for the transduction of extracellular signals into
responses in the cytosol, nucleus and mitochondria
through protein phosphorylation [13-16]. Factors elicit-
ing MAPK signal transduction are identified including
proinflammatory cytokines, growth factors, estrogens,
and mitochondrial reactive oxygen species (ROS) e.g.
thioredoxin [14-17]. The most well-characterized MAPK
cascade consists of extracellullar signal-regulated (ERK)
kinases MEK1/2 and ERK 1/2 (p42/p44), stress-activated
protein kinases (SAPK) i.e. c-Jun amino-terminal kinase
(JNK) and reactivating protein kinase (p38MAPK) [13-
15]. Activation of MAPKs is mediated by upstream phos-
phorylation via MAPK kinases (MAPKKs) [14,15,18,19].
Once activated, MAPKs predominantly regulate gene
expression via phosphorylation of downstream transcrip-
tion factors, which include the proinflammatory tran-
scription factors activator protein (AP)-1 and nuclear
factor (NF)-κB [15,16,19,21,22]. AP-1 is a collective term
referring to heterodimers formed by c-Jun, c-Fos or acti-
vating transcription factor subunits which bind to AP-1
responsive elements in gene promoters [17-20]. Despite
the high maternal plasma estradiol level present at term
pregnancy, the total nuclear estrogen receptor (ER) level
in the uterine cervix is markedly decreased as compared to
non-pregnant, suggesting a markedly limited nuclear ER
mediated biological response to estrogens at parturition
[7,9]. The aim of this study was to investigate the expres-
sion and distribution of MAPKs and their intracellular tar-
get transcription factor AP-1.
Materials and methods
Patients
The non-pregnant (NP) group consisted of healthy, regu-
larly menstruating women (n = 6) without medication,
undergoing hysterectomy due to benign disorders not
involving the cervix. Hysterectomies were carried out dur-
ing the follicular phase of the menstrual cycle within ten
days from the latest menstrual period, to avoid the risk for
an unknown pregnancy. The study subjects had a mean
age of 42 years (range 32–49), and a mean parity of 2 (1–
3). The term pregnant (TP) group consisted of healthy
women (n = 8) with a mean age of 32 years (range 28–
38), a mean gestational age of 38 weeks (range 37–39),
and a mean parity of 1 (range 1–2). All had unripe cervi-
ces as determined by a Bishop score of < 5 points and
none of them was in labor. Elective caesareans on medical
indications were carried out in all women. The postpar-
tum (PP) group consisted of primiparous, healthy women
(n = 9) with uncomplicated pregnancies, from whom
biopsies were obtained within 20 minutes after uncompli-
cated vaginal parturition. They had a mean age of 30 years
(range 23–37), and a mean gestational age of 40 weeks
(range 39–41).
Every woman had given her informed consent before
entering the study. The study was approved by the Karo-
linska Hospital Ethics Committee (96–187, 99–099).
Sampling procedure
The biopsies were obtained transvaginally from the ante-
rior part of the uterine cervix at the 12 o'clock position,
from 10–20 mm depth. The cervical biopsies were divided
and one half was immersion-fixed in 4 % formaldehyde at
4°C overnight, stored at 4°C in 70% ethanol and thereaf-
ter embedded in paraffin. One half was immediately fro-
zen at -70°C.
Immunohistochemistry
Paraffin sections (5 µm) were used as a standard immuno-
histochemical technique (avidin-biotin-peroxidase)
which was carried out as described before to visualize
MAPK (p42/44-ERK1/2, p38 and JNK) immunostaining
intensity and distribution [23]. Primary antibodies used
in this study are listed in Table 1. All antibodies were incu-
bated at 4°C overnight. Replacement of the primary anti-
body with an equivalent concentration of non-immune
mouse IgG (for monoclonal antibody) and rabbit IgG (for
polyclonal antibody) was used for negative controls.
Immunostaining analysis
A Leica microscope and Sony video camera (Park Ridge,
NJ, USA) connected to a computer (Leica Imaging System
Ltd, Cambridge, UK) was used to assess immunohisto-
chemistry results. Two sections of each sample were ana-
lysed and ten areas of cell compartment from each section
were randomly chosen for quantification of immunos-
taining intensity. The staining intensity was semiquantita-
tively graded (H.W.) by manual scoring as very strong (4)
when 80–100% cells were positive, strong (3) when 60–
80% of cells were positive, moderate (2) when 30–60% of
cells were positive, weak (1) when less than 30% of cells
were positive or as no staining (0).
RNA isolation and RT-PCR analyses
Frozen pieces of cervical tissue were processed for isola-
tion of total RNA according to the manual for the SV totalReproductive Biology and Endocrinology 2007, 5:3 http://www.rbej.com/content/5/1/3
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RNA isolation system (Promega, Madison, WI, USA). One
µg of total RNA were reversely transcribed at 42°C for 45
min in a final volume of 40 µl with a reaction mixture
containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM
MgCl2, 7.5 mM DTT, 0.5 mM dNTPs, 1 µg random hexam-
ers and 400 IU of ML-MTV reverse transcriptase (GIBO,
BRL, Paisley, UK). Primer sequences and the predicted
product size were for human c-fos gene: 5'-GGAT-
AGCCTCTCTTACTACCAC-3'; 5'-TCCTGTCATGGTCT-
TCACAACG-3' and 280 bp; the human c-jun gene: 5'-
GGAAACGACCTTCTATGACGATGCCCTCAA-3'; 5'-
GAACCCCTCCTGCTCATCTGTCACGTTCTT-3' which
amplify a 325 bp fragment and the human ribosomal pro-
tein S28 which was used as an internal control: 5'-
GTGCAGATCTTGGTGGTAGTAGC-3'; 5'-AGAGCCAATC-
CTTATCCCGAAGTT-3' and 552 bp. For PCR amplifica-
tion, the cDNA (corresponding to 50 ng RNA from the RT-
PCR reaction) was added to the reaction mixture contain-
ing 20 mM Tris-HCl pH 8.4. 50 mM KCl, 2.5 IU Tag DNA
polymerase (GIBCO, BRL, Paisley, UK), 0.2 mM dNTPs,
1.5 mM MgCl2, and oligonucleotide primer pairs (50
pmol/pair), with a final volume of 50 µl. PCR was per-
formed for 30 cycles using 94°C (30 s) for denaturing,
58°C (45 s) for annealing, 72°C (45 s) for extension and
a final incubation at 72°C for 3 min on a thermal cycler.
The products were subjected to electrophoresis in 2.5 %
agarose gels; data were analyzed using a Fujifilm Las-1000
system (Fujifilm, Japan). Statistical analyses were not per-
formed on this data.
Statistical analyses
Statistical calculations for the immunohistochemistry
results by image analysis of pMAPK were performed by
ANOVA on ranks (Kruskal-Wallis test) and significances
were evaluated by Dunn's test. One-way parametric
ANOVA was used for analyses of immunohistochemistry
results for c-Jun and c-Fos proteins.
Results
All three types of phosphorylated MAPKs were positively
stained in the cervix, in both cell nuclei and cytoplasm
(Figure 1 and 2). The distribution of pMAPKs by using dif-
ferent antibodies in the cervical connective tissue was
described as following:
ERK1/2 (p42/44)
ERK immunostaining was observed in different compart-
ments of the cervix by using non-phosphorylated and
phosphorylated (pERK1/2) antibodies. The staining
intensity was slightly higher by the non-phosphorylated
antibody (data not shown), although the staining patterns
did not differ significantly by these two types of antibod-
ies. In cervical stroma, pERK1/2 expression was the lowest
in the NP group, and increased in TP and PP groups as
compared to NP (P < 0.05) (Figure 1A–D and Figure 3A).
In the subepithelial mucosa area, intensive immunostain-
ing was present in the stromal cells in all study groups. In
smooth muscle, the pERK1/2 expression was unchanged
between the groups (data not shown). The endothelial
cells of blood vessels (vein) displayed high pERK1/2
expression in NP group, but weak or absent in TP and PP
groups as compared to NP (P < 0.01) (Figure 1A,C and
Figure 3A). No immunostaining for pERK 1/2 was found
in glandular epithelium (Figure 1B,D).
JNK
The phosphorylated JNK (pJNK) immunostaining was
mainly localized to the cell nuclei, whereas non-phospho-
rylated JNK staining was found in both cytosol and nuclei
(data not shown). In cervical stroma, pJNK expression was
Table 1: Primary antibodies used in this study.
Antibody Specificity Dilution Sources
c-fos (Ab-2) Polyconal 
(PC05)
Amonio acid residues 4–17 of human c-Fos 1:40 Oncogene Research Products, 
Cambridge, MA
c-Jun (Ab-2) Polyclonal 
(PC07)
Amonio acid residues 91–105 of human c-Jun 1:40 Oncogene Research Products, 
Cambridge, MA
Phopho-specific P44/42 MAPK polyclonal Ab 
(9101S)
Amonio acid residues 91–105 of human p44 MAP 
kinase, detects p42 and p44 MAPK (Erk1 and Erk2), 
only when activated by phosphorylation at Thr 202 
and Tyr 204
1:250 New England Biolabs, Inc. 
Beverly, MA
P44/42 MAPK polyclonal Ab 
(9102)
Amonio acid residues 345–358 of rat p42 MAPK, 
detects total MAP kinase (Erk1 and Erk2) levels
1:1000 New England Biolabs, Inc. 
Beverly, MA
Phospho-p38 MAPK polyclonal Ab 
(9211S)
A synthetic doubly phosphorylated peptide (Thr 180/
Tyr 182) of human p38 MAPK
1:500 New England Biolabs, Inc. 
Beverly, MA
p-JNK (G-7) Monoclonal AB 
(sc-6254)
A short aa sequence containing phosphorylated on 
Thr-183 and Tyr-185 of JNK1 of human, reacts to 
phosporylated JNK 1–3
1:250 Santa Cruz Biotechnology, Inc. 
USA
JNK2 (D-2) Monoclonal AB 
(sc-7345)
Full lengh (aa 1–424) human JNK2, reacts to JNK1-3 1:250 Santa Cruz Biotechnology, Inc. 
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Representative sections showing the expression and distributions of pERK and pJNK in different cell types of the uterine cervix  by using phospho-antibodies, as shown in non-pregnant (NP) and postpartum (PP) groups Figure 1
Representative sections showing the expression and distributions of pERK and pJNK in different cell types of the uterine cervix 
by using phospho-antibodies, as shown in non-pregnant (NP) and postpartum (PP) groups. Cervical stroma, blood vessels 
shown in A, C, E, G. Glandular epithelium and subepithelial mucosa area of stroma shown in B, D, F and H.
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Representative cervical sections from non-pregnant (NP) (A-B), term pregnant (TP) (C-D) and postpartum (PP) groups (E-F),  showing the the expression and distribution of p38MAPK in different cells by using phospho-antibodies Figure 2
Representative cervical sections from non-pregnant (NP) (A-B), term pregnant (TP) (C-D) and postpartum (PP) groups (E-F), 
showing the the expression and distribution of p38MAPK in different cells by using phospho-antibodies. Stroma and blood ves-
sels (A, C and E). Glandular epithelium and subepithelial mucosa area of stroma (B, D and F).
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the lowest in the NP group, but significantly increased and
high in TP and PP groups as compared to NP (P < 0.05)
(Figure 1E–H and Figure 3B). In the subepithelial mucosa
area, pJNK staining was present in some stromal cells in
all study groups. High intensity pJNK staining was gener-
ally found in glandular epithelium but without significant
changes between the study groups (Figure 1F,H). Vascular
endothelial pJNK expression did not differ between the
groups (Figure 1E,G and Figure 3B).
p38MAPK
Only the phosphorylated-specific antibody for p38MAPK
was used. A reciprocal pattern för p38MAPK expression
was observed in cervical stroma in comparison to vascular
endothelium between NP and TP groups (Figure 3C).
High intensity p38MAPK immunostaining was present in
the vascular endothelium in NP and TP groups and absent
in PP group (P < 0.01) (Figure 2A,C (magnification), E
(arrow head), and Figure 3C). p38MAPK expression in
stroma was significantly increased in TP as compared to
NP group (P < 0.05) (Figure 2 and Figure 3C). In the sub-
epithelial mucosa area, p38MAPK staining was present in
stroma cells in all study groups, but less intensive in the
PP group (Figure 2B,D,F).
c-Jun
Immunoreactivity for c-Jun protein was present in all cel-
lular compartments in NP, TP and PP groups (Figure 4). c-
Jun expression was significantly increased in cervical
stroma (P < 0.01) and smooth muscle (P < 0.001) in TP as
compared to NP group (Figure 5). The changes in vascular
endothelium, squamous epithelium and glandular epi-
thelium did not differ between the groups.
c-Fos
Immunoreactivity for c-Fos protein was present in all cel-
lular compartments in NP, TP and PP groups, as shown in
Figure 4. c-Fos expression was increased in cervical stroma
(P < 0.01), squamous epithelium (P < 0.01) and glandular
epithelium (P < 0.05) in PP as compared to TP group (Fig-
ure 6). The changes in vascular endothelium and smooth
muscle did not differ between the groups.
RT-PCR
Figure 7. illustrates the presence of c-jun and c-fos mRNAs
in human uterine cervix in term pregnancy and immedi-
ately after parturition. S28 was used as a standard to ena-
ble comparison of the amount of RNA loaded to each
well.
Discussion
This study demonstrates alterations in the expression and
distribution of the phosphorylated, activated MAPK forms
and in their intracellular target transcription factor AP-1 in
human uterine cervix at term pregnancy and immediately
after parturition. To our knowledge, this is the first study
identifying pMAPK activation in human uterine cervix.
Rusycky [24] was the first to report an increase in MAPK
cascade in vivo in rat myometrium with advancing gesta-
tion, and a decrease immediately before birth. Otun and
collaborators [25] have described significantly elevated
expressions of p38MAPK and ERK1 in the upper uterine
segment at term and during labor, whereas ERK2 expres-
sion remained unchanged.
Proinflammatory cytokines increase exponentially in the
uterus and cervix at the time for parturition [1,8,26-28].
The immunostaining scores for pERK1/2 (A), pJNK (B) and p38MAPK (C) in cervical stroma and vascular endothelium in biop- sies from non-pregnant (NP, n = 6), term pregnant (TP, n = 8) and postpartum (PP, n = 9) groups respectively Figure 3
The immunostaining scores for pERK1/2 (A), pJNK (B) and p38MAPK (C) in cervical stroma and vascular endothelium in biop-
sies from non-pregnant (NP, n = 6), term pregnant (TP, n = 8) and postpartum (PP, n = 9) groups respectively. For stroma fig-
ures with different letter designation are significantly different (P < 0.05). For blood vessels significant values are marked with * 
for P < 0.05, and with ** for P < 0.01 respectively.
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Mechanical stretch and hypoxia are physiological features
in the uterine and cervical tissues during gestation, which
escalate with labor [27]. Proinflammatory interleukin
(IL)-1β and mechanical stretch act through MAPKs to
increase inducible cyclooxygenase (COX)-2 and IL-8
expression in human uterine myocytes [27]. Evidence sug-
gests that some effect of mechanical tension could be
mediated through an increased IL-1β level [27]. The acti-
vation of MAPK signaling observed in the present study
may therefore be caused by elevated proinflammatory
cytokine levels, mechanical tension and hypoxia in the
lower uterine segment.
A high density of p38MAPK was observed in vascular
endothelium at term pregnancy. Previous studies have
shown, that p38MAPK facilitates the adhesion of leuko-
cytes to endothelial cell integrins, chemotaxis, leukocyte
oxidative burst and release of IL-1β and elastase [14,28].
The increased endothelial p38MAPK expression in term
pregnancy, therefore, indicates that p38MAPK facilitates
leukocyte extravasation in the uterine cervix before partu-
rition.
The glandular epithelium displayed a high immunostain-
ing intensity particularly for pJNK and for p38MAPK, but
without changes between the groups. Uterine glandular
epithelium is known to be a source of cytokine synthesis
[29]. The comparable pJNK and p38MAPK expressions
could be due to the limited number of samples or, alter-
natively, depend on an unchanged rate of glandular epi-
thelial pMAPK activation in cervical ripening at
parturition.
Cervical stroma, which is composed of 70–80% fibrous
connective tissue and 5–15% smooth muscle [30] dis-
played increased immunostaining for all pMAPKs at term
pregnancy, and an elevated pERK1/2 expression immedi-
ately after parturition. The expressions of proinflamma-
tory transcription factors AP-1 and NFκB are increased in
the cervical stoma at the time for parturition [31]. MAPK
cascades, and estrogens, activate AP-1 and NFκB
[15,16,19,21,22]. MAPKs and NFκB also activate the pros-
taglandin synthases phospholipase (PL) A2 and inducible
COX-2 [5,18,26,27]. The collagen digesting enzyme met-
alloproteinase (MMP)-1 gene contains an AP-1 response
Representative sections showing the expression and distributions of c-Fos and c-Jun proteins (AP-1) in different cell types of  cervical samples from non-pregnant (NP), term pregnant (TP) and postpartum (PP) groups Figure 4
Representative sections showing the expression and distributions of c-Fos and c-Jun proteins (AP-1) in different cell types of 
cervical samples from non-pregnant (NP), term pregnant (TP) and postpartum (PP) groups. Stroma and blood vessels for c-Fos 
shown in in A, C, E and for c-Jun shown in G, I, K (magnification vein). Glandular epithelium and subepithelial mucosa area of 
stroma, shown for c-Fos in B, D, F and for c-Jun in H, J, L.
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element in its promoter region [32]. Thus, activation of
MAPKs and their targets AP-1 and NFκB in the uterine cer-
vix could promote cervical ripening through an increased
prostaglandin synthesis and an enhanced collagenolysis
[6-8,26,27,31]. Nuclear ER mediated activation of MAPKs
is unlikely. Despite an exponentially increased maternal
plasma estradiol concentration reaching 200 nmol/L at
term pregnancy, the total cervical nuclear ER level is mark-
edly decreased, and inhibitory ERβ subtype enhanced, as
compared to the non-pregnant state. This suggests that the
nuclear ER mediated genomic response is very limited at
parturition [7,12]. Our findings are in agreement with
previous reports, which have showed that estrogens at
high concentrations evoke early events such as inflamma-
tory cell influx, activation of MAPK pathways, adenyl
cyclase (AC) and protein kinase C (PKC) [15,33,34].
Estradiol at low concentrations, comparable to the circu-
lating levels during the menstrual cycle, elicits nuclear ER
genomic activation, which requires hours or days for max-
imal gene activation [15-17,21,22,34].
In conclusion, our observations indicate activation of
MAPK cascades, and increased expressions of their targets
transcription factors AP-1 and NFκB [31] in human uter-
ine cervix before labor. These results suggest a role for
MAPK phosphorylation in cervical ripening at parturition.
The exact mechanism behind MAPK activation should be
a topic for future studies.
The immunostaining scores for c-Jun in different cell types in cervical biopsies from non-pregnant (NP, n = 2), term pregnant  (TP, n = 4) and postpartum (PP, n = 8) groups Figure 5
The immunostaining scores for c-Jun in different cell types in cervical biopsies from non-pregnant (NP, n = 2), term pregnant 
(TP, n = 4) and postpartum (PP, n = 8) groups. c-Jun immunoreactivity was significantly increased in cervical cervical stroma (P 
< 0.01) and smooth muscle (P < 0.001) in TP as compared to NP group. Changes in vascular endothelium, squamous epithe-
lium and glandular epithelium did not differ between the groups. Wilks lambda = 0.07. F10,16 = 4.03.
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The immunostaining scores for c-Fos in different cell types in cervical biopsies from non-pregnant (NP, n = 2), term pregnant  (TP, n = 4) and postpartum (PP, n = 8) groups Figure 6
The immunostaining scores for c-Fos in different cell types in cervical biopsies from non-pregnant (NP, n = 2), term pregnant 
(TP, n = 4) and postpartum (PP, n = 8) groups. c-Fos immunoreactivity was significantly increased in cervical stroma (P < 0.01), 
squamous epithelium (P < 0.01) and glandular epithelium (P < 0.05) in PP as compared to TP group. Changes in vascular 
endothelium and smooth muscle did not differ between the groups. Wilks lambda = 0.14. F10,16 = 2.70, P > 0.05.
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The presence of c-jun and c-fos mRNAs in 17 samples from the human uterine cervix as detected by RT-PCR analysis Figure 7
The presence of c-jun and c-fos mRNAs in 17 samples from the human uterine cervix as detected by RT-PCR analysis. Non-
pregnant (NP, n = 6), term pregnant (TP, n = 5) and postpartum (PP, n = 6) groups. 28S was used as an internal standard to 
enable the comparison of the amount of mRNA loaded to each well.
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